FLUOROURACIL INJECTION 5 G / 100 ML
FLUOROURACIL : 5 G / 100 ML · DIN 02473771 · BIOLYSE PHARMA CORPORATION
Health Canada status: MARKETED
What is FLUOROURACIL INJECTION?
FLUOROURACIL INJECTION 5 G / 100 ML contains FLUOROURACIL : 5 G / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02473771, held by BIOLYSE PHARMA CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 06-Jun-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02473771 |
|---|---|
| Brand name | FLUOROURACIL INJECTION |
| Generic / active ingredient | FLUOROURACIL : 5 G / 100 ML |
| Manufacturer | BIOLYSE PHARMA CORPORATION |
| Strength | 5 G / 100 ML |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01BC02 FLUOROURACIL |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Jun-2019 |
| Original market date | 2019-10-30 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code L01BC02 FLUOROURACIL. 6 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EFUDEX | 5 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 00330582 |
| FLUOROURACIL INJECTION | 0.5 G / 10 ML | SOLUTION | BIOLYSE PHARMA CORPORATION | MARKETED | DIN 02473763 |
| FLUOROURACIL INJECTION | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00012882 |
| FLUOROURACIL INJECTION USP | 50 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED | DIN 02413450 |
| TOLAK | 4 % | CREAM | HILL DERMACEUTICALS INC | MARKETED | DIN 02485346 |
| ADRUCIL | 50 MG | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02063921 |
| ADRUCIL INJ 50MG/ML | 500 MG / 10 ML | LIQUID | ADRIA LABORATORIES OF CANADA LTD. | CANCELLED POST MARKET | DIN 00428493 |
| FLUOROPLEX CREAM 1% | 1 % | CREAM | ALLERGAN HERBERT SKIN CARE DIVISION OF ALLERGAN INC. | CANCELLED POST MARKET | DIN 01982311 |
| FLUOROURACIL INJ 50MG/ML | 50 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 00891754 |
| FLUOROURACIL INJECTION | 1000 MG / 20 ML | SOLUTION | GENERIC MEDICAL PARTNERS INC | APPROVED | DIN 02476746 |
Who else supplies FLUOROURACIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUOROURACIL appears in 63 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.